Int J Cancer. 1997 Dec 10;73(6):781-5. Unique Identifier : AIDSLINE
To investigate a possible cause-and-effect relationship between sexually
transmitted diseases and cervical cancer, we performed a
sero-epidemiological study on the presence of antibodies against a
number of sexually transmitted agents (STAs) in patients with cervical
cancer and their matched controls. In this study, we used serological
techniques to investigate the presence of antibodies to cytomegalovirus,
herpes simplex virus type 2, human immunodeficiency virus, Chlamydia
trachomatis, Treponema pallidum and human papillomavirus (HPV) early
protein E7 in sera from patients with cervical cancer, cervical
intra-epithelial neoplasia and individually matched, healthy controls.
The presence of antibodies to infectious agents other than HPV appeared
not to be associated with risk of cervical neoplasia in either
univariate or multivariate analysis. After adjustment for cytology,
schooling and presence of HPV DNA in cervical scrapes, there was a
significantly higher prevalence of antibodies to HPV-16 E7 protein in
sera from patients with cervical cancer (OR = 3.6, 95% CI 1.0-12.9) than
in healthy controls. The highest antibody prevalence was found among
HPV-16 DNA-positive cervical cancer patients (33%). Our results indicate
that in these study groups past infections with the STA considered seems
to be of no apparent relevance for cervical carcinogenesis and that the
HPV-16 anti-E7 response appears to be associated with cervical cancer.
*Antibodies, Bacterial/BLOOD *Antibodies, Viral/BLOOD *Cervix
Neoplasms/EPIDEMIOLOGY *Sexually Transmitted Diseases,
Viral/EPIDEMIOLOGY